Lithotripsy devices for percutaneous nephrolithotomy (PNL) - new developments.


Journal

Current opinion in urology
ISSN: 1473-6586
Titre abrégé: Curr Opin Urol
Pays: United States
ID NLM: 9200621

Informations de publication

Date de publication:
01 07 2022
Historique:
pubmed: 9 6 2022
medline: 29 6 2022
entrez: 8 6 2022
Statut: ppublish

Résumé

Percutaneous nephrolithotomy (PNL) is the mainstay of surgery for renal calculi>2 cm or complex multiple calculi and is a technique that has been around since 1976. We review recent literature surrounding novel lithotripsy devices and technology used in PNL. At present, the Holmium:yttrium-aluminum-garnet (Ho:YAG) laser is widely accepted as the gold standard laser lithotripsy for PNL. SwissLithoClast Trilogy offers a range of probes with a trifecta of electromagnetic, ultrasonic energy with surgeon-controlled suction. The Olympus Shockpulse-SE is a similar lithotripter that relies on continuous ultrasonic energy with pulsed ballistic energy to break stones. Thulium Fiber Laser (TFL) offers an alternative laser energy source to the Holmium laser, which has been shown to be very effective at producing small stone fragments and dust. The Moses technology is another addition in a long list of improvements to the Ho:YAG laser, forming vaporization bubble through which more effective energy can be applied to stones. Trilogy, Shockpulse, TFL and Moses pulse modulation technology for the Holmium laser all provide improvements compared with older lithotripsy devices. In particular, they convey a safer, efficient and more effective way to manage and clear stones.

Identifiants

pubmed: 35674683
doi: 10.1097/MOU.0000000000000996
pii: 00042307-202207000-00011
doi:

Substances chimiques

Thulium 8RKC5ATI4P

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

405-410

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Références

Patel SR, Nakada SY. The modern history and evolution of percutaneous nephrolithotomy. https://www.liebertpub.com/doi/10.1089/end.2014.0287 . 2015; 29:153-157.
Türk C, Neisius A, Petrik A, et al. EAU guidelines on urolithiasis. Eur Assoc Urol 2018; 2018:1–87. http://www.ncbi.nlm.nih.gov/pubmed/26344917%5Cnhttp://uroweb.org/wp-content/uploads/22-Urolithiasis_LR_full.pdf
Castellani DD, Corrales DM, Lim MEJ, et al. The impact of lasers in percutaneous nephrolithotomy outcomes: results from a systematic review and meta-analysis of randomized comparative trials. J Endourol 2022; 36:151–157.
Ganpule AP, Desai MR. What's new in percutaneous nephrolithotomy. Arab J Urol 2012; 10:317–323.
Sabnis RB, Balaji SS, Sonawane PL, et al. EMS Lithoclast Trilogy TM : an effective single-probe dual-energy lithotripter for mini and standard PCNL. World J Urol 2020; 38:1043–1050.
Wollin D, Carlos E, Winship B, et al. MP68-13 the next generation: in vitro comparison of a novel single-probe dual-energy lithotripter to current devices. J Urol 2018; 199 (4S):e921–e922.
Bader MJ, Strittmatter F, Alghamdi A, et al. Endoscopic clearance lithotripsy devices bench comparison of stone elimination capacity and drilling speed. World J Urol 2021; 39:563–569.
Khoder W, Strittmatter F, Alghamdi A, et al. Comparative evaluation of tissue damage induced by ultrasound and impact dual-mode endoscopic lithotripsy versus conventional single-mode ultrasound lithotripsy. World J Urol 2020; 38:1051–1058.
Nottingham CU, Large T, Cobb K, et al. Initial clinical experience with Swiss LithoClast trilogy during percutaneous nephrolithotomy. J Endourol 2020; 34:151–155.
Thakare N, Tanase F, Saeb-Parsy K, et al. Efficacy and safety of the EMS Swiss LithoClast® Trilogy for PCNL: results of the European multicentre prospective study on behalf of European Section of UroTechnology. World J Urol 2021; 39:4247–4253.
Patil A, Sharma R, Shah D, et al. A prospective comparative study of mini-PCNL using Trilogy™ or thulium fibre laser with suction. World J Urol 2021; 40:539–543.
Carlos EC, Wollin DA, Winship BB, et al. In vitro comparison of a novel single probe dual-energy lithotripter to current devices. J Endourol 2018; 32:534–540.
Strittmatter F, Nagele U, Schachtner J, et al. Evaluation of intrarenal pressure stability at different lithotripter suction settings in a porcine kidney model. World J Urol 2021; 39:3665–3670.
Feng D, Zeng X, Han P, et al. Comparison of intrarenal pelvic pressure and postoperative fever between standard- and mini-tract percutaneous nephrolithotomy: a systematic review and meta-analysis of randomized controlled trials. Transl Androl Urol 2020; 9:1159–1166.
Large T, Nottingham C, Brinkman E, et al. Multi-institutional prospective randomized control trial of novel intracorporeal lithotripters: ShockPulse-SE vs Trilogy Trial. J Endourol 2021; 35:1326–1332.
Lattarulo M, Tsaturyan A, Adamou C, et al. Comparative evaluation between one ultrasonic and two single-probe dual-energy lithotripters: in vitro and in vivo experiment in a porcine model. J Endourol 2021; 35:1229–1235.
Axelsson TA, Cracco C, Desai M, et al. Consultation on kidney stones, Copenhagen 2019: lithotripsy in percutaneous nephrolithotomy. World J Urol 2021; 39:1663–1670.
Chew BH, Matteliano AA, De Los Reyes T, et al. Benchtop and initial clinical evaluation of the ShockPulse stone eliminator in percutaneous nephrolithotomy. J Endourol 2017; 31:191–197.
Yadav BK, Basnet RB, Shrestha A, et al. Comparison between shockpulse and pneumatic lithotripsy in percutaneous nephrolithotomy. World J Urol 2020 393 2020; 39:915–919.
Bader MJ, Eisel M, Strittmatter F, et al. Comparison of stone elimination capacity and drilling speed of endoscopic clearance lithotripsy devices. World J Urol 2021; 39:563–569.
Traxer O, Keller EX. Thulium fiber laser: the new player for kidney stone treatment? A comparison with Holmium:YAG laser. World J Urol 2020; 38:1883–1894.
Kronenberg P, Hameed BZ, Somani B. Outcomes of thulium fibre laser for treatment of urinary tract stones: results of a systematic review. Curr Opin Urol 2021; 31:80–86.
Enikeev D, Taratkin M, Klimov R, et al. Thulium-fiber laser for lithotripsy: first clinical experience in percutaneous nephrolithotomy. World J Urol 2020; 38:3069–3074.
Hardy LA, Vinnichenko V, Fried NM. High power holmium:YAG versus thulium fiber laser treatment of kidney stones in dusting mode: ablation rate and fragment size studies. Lasers Surg Med 2019; 51:522–530.
Panthier F, Doizi S, Berthe L, et al. Comparison of the fissures and fragments produced with 150 mm and 272 mm laser fibers with superpulsed thulium fiber laser: An in vitro study. Eur Urol Open Sci 2020; 39 (6):1683–1691.
Korolev D, Akopyan G, Tsarichenko D, et al. Minimally invasive percutaneous nephrolithotomy with SuperPulsed Thulium-fiber laser. Urolithiasis 2021 495 2021; 49:485–491.
Petzold R, Suarez-Ibarrola R, Miernik A. Temperature assessment of a novel pulsed thulium solid-state laser compared with a Holmium:Yttrium-Aluminum-Garnet Laser. J Endourol 2021; 35:853–859.
Khusid JA, Khargi R, Seiden B, et al. Thulium fiber laser utilization in urological surgery: A narrative review. Investig Clin Urol 2021; 62:136–147.
Matsuoka K, Iida S, Nakanami M, et al. Holmium: yttrium-aluminum-garnet laser for endoscopic lithotripsy. Urology 1995; 45:947–952.
Jeon SS, Hyun JH, Lee KS. A comparison of holmium:YAG laser with Lithoclast lithotripsy in ureteral calculi fragmentation. Int J Urol 2015; 10:185–188.
Grasso M. Experience with the holmium laser as an endoscopic lithotrite. Urology 1996; 48:199–206.
Teichman JMH, Vassar GJ, Glickman RD. Holmium:yttrium-aluminum-garnet lithotripsy efficiency varies with stone composition. Urology 1998; 52:392–397.
Becker B, Gross AJ, Netsch C. Ho:YaG laser lithotripsy: recent innovations. Curr Opin Urol 2019; 29:103–107.
Pietropaolo A, Jones P, Whitehurst L, et al. Role of ‘dusting and pop-dusting’ using a high-powered (100 W) laser machine in the treatment of large stones (≥ 15 mm): prospective outcomes over 16 months. Urolithiasis 2019; 47:391–394.
Elhilali MM, Badaan S, Ibrahim A, et al. Use of the Moses Technology to improve holmium laser lithotripsy outcomes: a preclinical study. J Endourol 2017; 31:598–604.
Winship B, Wollin D, Carlos E, et al. Dusting efficiency of the moses holmium laser: an automated in vitro assessment. J Endourol 2018; 32:1131–1135.
Dunne M, Drescher M, Abbott J, et al. MP18-04 LUMENIS PULSE ™ MOSES ™ Technology improves efficiency of laser lithotripsy for patients undergoing Mini-PCNL. J Urol 2021; 206: (Supplement 3): 318.
Ibrahim A, Elhilali MM, Fahmy N, et al. Double-blinded prospective randomised clinical trial comparing regular and Moses modes of holmium laser lithotripsy. J Endourol 2020; 34:624–628.
Pietropaolo A, Hughes T, Mani M, et al. Outcomes of ureteroscopy and laser stone fragmentation (URSL) for kidney stone disease (KSD): comparative cohort study using MOSES technology 60 W laser system versus regular holmium 20 W laser. J Clin Med 2021; 10:2742.
Geraghty RM, Jones P, Herrmann TRW, et al. Ureteroscopy is more cost effective than shock wave lithotripsy for stone treatment: Systematic review and meta-analysis. World J Urol 2018; 36:1783–1793.
Somani BK, Robertson A, Kata SG. Decreasing the cost of flexible ureterorenoscopic procedures. Urology 2011; 78:528–530.
Stern KL, Monga M, Tianming GA. The Moses holmium system-time is money. Can J Urol 2018; 25:9313–9316.
Aldoukhi AH, Black KM, Shields J, et al. Ambulatory tubeless mini-percutaneous nephrolithotomy using Moses Technology and dusting technique. Urology 2019; 124:306.
Geraghty RM, Cook P, Walker V, et al. Evaluation of the economic burden of kidney stone disease in the UK: a retrospective cohort study with a mean follow-up of 19 years. BJU Int 2020; 125:586–594.
New F, Somani BK. A Complete World Literature Review of Quality of Life (QOL) in Patients with Kidney Stone Disease (KSD). Curr Urol Rep 2016; 17:1–6.

Auteurs

Vaki Antoniou (V)

University Hospital Southampton NHS Trust, Southampton, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH